James Gordon
Stock Analyst at JP Morgan
(2.96)
# 1,589
Out of 5,090 analysts
10
Total ratings
100%
Success rate
28.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Gordon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARGX argenx SE | Maintains: Overweight | $830 → $925 | $901.17 | +2.64% | 7 | Nov 7, 2025 | |
| GRFS Grifols | Maintains: Neutral | $7.6 → $10 | $8.85 | +16.38% | 1 | Jun 17, 2025 | |
| GMAB Genmab | Downgrades: Neutral | n/a | $31.74 | - | 1 | Aug 20, 2024 | |
| FGEN FibroGen | Upgrades: Neutral | n/a | $8.42 | - | 1 | Apr 7, 2021 |
argenx SE
Nov 7, 2025
Maintains: Overweight
Price Target: $830 → $925
Current: $901.17
Upside: +2.64%
Grifols
Jun 17, 2025
Maintains: Neutral
Price Target: $7.6 → $10
Current: $8.85
Upside: +16.38%
Genmab
Aug 20, 2024
Downgrades: Neutral
Price Target: n/a
Current: $31.74
Upside: -
FibroGen
Apr 7, 2021
Upgrades: Neutral
Price Target: n/a
Current: $8.42
Upside: -